Adjuvant Global Health Technology Fund, L.P.

Business address
C/O Adjuvant Capital, L.P., 501 Fifth Avenue, Suite 1404, New York, NY, 10017
State of incorporation
Cayman Islands
Get insider transactions for this reporting owner
Adjuvant Global Health Technology Fund, L.P. has filed 19 SEC EDGAR filings since 8/5/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open Document Open Filing Feb 28, 2025
SC 13G/A Open Document Open Filing SC 13G/A Feb 9, 2024
4 Open Document Open Filing 4 Jan 18, 2024 Jan 16, 2024 001-41331
144 Open Document Open Filing Jan 16, 2024
4 Open Document Open Filing 4 Nov 16, 2023 Nov 14, 2023 001-41331
4 Open Document Open Filing 4 Oct 3, 2023 Sep 29, 2023 001-41331
4 Open Document Open Filing 4 Sep 29, 2023 Sep 27, 2023 001-41331
4 Open Document Open Filing 4 Sep 15, 2023 Aug 23, 2023 001-41331
4 Open Document Open Filing 4 Sep 8, 2023 Aug 23, 2023 001-41331
4 Open Document Open Filing 4 Aug 25, 2023 Aug 23, 2023 001-41331
SC 13G Open Document Open Filing SC 13G Feb 10, 2023
4 Open Document Open Filing FORM 4 SUBMISSION Jun 24, 2022 Jun 6, 2022 001-41331
4/A Open Document Open Filing FORM 4/A SUBMISSION Jun 24, 2022 Mar 29, 2022 001-41331
3/A Open Document Open Filing FORM 3/A SUBMISSION Jun 24, 2022 Mar 24, 2022 001-41331
4 Open Document Open Filing FORM 4 SUBMISSION Mar 31, 2022 Mar 29, 2022 001-41331
3 Open Document Open Filing FORM 3 SUBMISSION Mar 24, 2022 Mar 24, 2022 001-41331
D/A Open Document Open Filing Feb 23, 2021 021-345780
D/A Open Document Open Filing Jan 17, 2020 021-345780
D Open Document Open Filing Aug 5, 2019 021-345780